🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study aims to assess quabodepistat-based treatment regimens for RR/MDR...
Status
Recruiting
Location
Capital Medical University - Beijing Chest Hospital
Start Date
2025-10-16
Trial ID
NCT07209761
The UNITE4TB consortium is a group of universities and pharmaceutical compa...
Status
Recruiting
Location
PMSI Institute of Pneumology "Chiril Draganiuc"
Start Date
2024-01-09
Trial ID
NCT06114628
To evaluate the efficacy, safety and tolerability of various doses and dura...
Status
Completed
Location
National Center for Tuberculosis and Lung Diseases
Start Date
2017-11-21
Trial ID
NCT03086486
Treatments Being Tested
The goal of this clinical trial is to evaluate 3 dose levels of TBAJ876 for...
Status
Active Not Recruiting
Location
National Center for Tuberculosis and Lung Diseases
Start Date
2023-10-31
Trial ID
NCT06058299
Treatments Being Tested
The treatment of rifampicin-resistant/multidrug-resistant pulmonary tubercu...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-09-30
Trial ID
NCT07191834
The purpose of this study is to determine if nicotinamide in combination wi...
Status
Suspended
Location
Wits RHI - Shandukani Research
Start Date
2026-04-17
Trial ID
NCT07517445
Existing problem with DR TB management: Injectable regimens for longer dur...
Status
Unknown
Location
S N Medical College
Start Date
2021-10-07
Trial ID
NCT05040126
Treatments Being Tested
This is a randomized controlled clinical trial comparing treatment success ...
Status
Terminated
Location
King Dinuzulu Hospital
Start Date
2017-06-14
Trial ID
NCT03237182
Treatments Being Tested
This two-stage study will compare consented research participants with tube...
Status
Recruiting
Location
Infectious Diseases Institute
Start Date
2026-07-28
Trial ID
NCT07227779
Treatments Being Tested
PRISM-TB is an international, seamless, multicenter, open-label, randomized...
Status
Recruiting
Location
National Center for Communicable Diseases
Start Date
2025-10-03
Trial ID
NCT06441006